Stories written by
S Srinivasan
-
India’s new clinical trial rules weaken safety nets for participants
The new rules promote easier clinical research in India but do little to improve safety and compensation for participants.
S Srinivasan
-
Bad news for patients as the government weakens the drug price regulator and meddles with price caps
A new committee has been set up to make recommendations to the National Pharmaceutical Pricing Authority and, in effect, take over its function.
S Srinivasan
-
Indian government may ask doctors to prescribe medicines under generic names. Is it practical?
With branded drugs making up 90% of the market, the move may end up missing the wood for the trees.
S Srinivasan
Trending
-
Kotak firm’s Rs 60 crore donation to BJP coincided with crucial RBI decisions on Kotak Mahindra Bank
-
Bharti group’s Rs 150 crore bond donation to BJP coincided with Modi government’s telecom U-turn
-
‘The Goat Life’ review: A protracted saga of suffering and survival
-
When an emperor came calling on a newly independent India to learn from its early successes
-
How the high demand for coaching classes reflects India’s employment and economic distress